Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Paolo Bonfanti and Nicola Squillace.
Paolo Bonfanti
Connection Strength
1.303
Nicola Squillace
  1. Therapy of Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: Is There an Optimal Interleukin 6 Cutoff for Successful Tocilizumab Treatment? Clin Infect Dis. 2021 07 01; 73(1):e270-e271.
    View in: PubMed
    Score: 0.954
  2. The Role for Tocilizumab in COVID-19 Patients: Reflections on Monza Cohort Data. Infect Drug Resist. 2021; 14:1389-1392.
    View in: PubMed
    Score: 0.235
  3. Factors associated with hospital admission for COVID-19 in HIV patients. AIDS. 2020 11 01; 34(13):1983-1985.
    View in: PubMed
    Score: 0.057
  4. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. J Transl Med. 2020 10 21; 18(1):405.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.